Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare providers & services stocks, including McKesson (NYSE:MCK) and its peers.
McKesson currently trades at $660.88 and has been a dream stock for shareholders. It’s returned 402% since March 2020, more than tripling the S&P 500’s 118% gain. The company has also beaten the index over the past six months as its stock price is up 38%.
As recession indicators begin to flash, investors may turn to defensive plays for protection—these three stocks offer a compelling case for sturdiness.
Take a gander at these three stocks that are generating returns on invested capital (ROIC) that are among the best in the U.S. large-cap stock universe.
Healthcare distributor and services company McKesson (NYSE:MCK) fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 17.8% year on year to $95.29 billion. Its non-GAAP profit of $8.03 per share was in line with analysts’ consensus estimates.
It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set for Friday morning. The S&P 500 and the Nasdaq 100 edged up 0.3%, while the Dow Jones slipped 0.1% and small caps held steady.
